Profil
Christopher Watt worked as a Senior Vice President-Finance at Tetraphase Pharmaceuticals, Inc. from 2017 to 2020 and as a Vice President-Finance at Biogen, Inc. from 2015 to 2017.
Prior to that, he earned an MBA from the University of Michigan and an undergraduate degree from Colby College.
Anciens postes connus de Christopher Watt
| Sociétés | Poste | Fin |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Directeur Financier/CFO | 28/07/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/07/2015 |
Formation de Christopher Watt
| Colby College | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
